ANI Pharmaceuticals Inc
NASDAQ:ANIP
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Price:
74.67
USD
-0.2%
Market Closed
Market Cap:
$1.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
US |
|
Singapore Land Group Ltd
SGX:U06
|
SG |
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
US |
|
N
|
New Tech Venture SA
WSE:NTV
|
PL |
|
Tokyu Corp
TSE:9005
|
JP |
|
Future Enterprises Ltd
NSE:FEL
|
IN |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
US |
|
Samsung Life Insurance Co Ltd
KRX:032830
|
KR |
|
Bridgestone Corp
TSE:5108
|
JP |
Balance Sheet
Balance Sheet Decomposition
ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc
Balance Sheet
ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
5
|
9
|
1
|
0
|
8
|
16
|
12
|
30
|
38
|
57
|
0
|
11
|
169
|
155
|
27
|
31
|
43
|
62
|
8
|
100
|
48
|
221
|
145
|
286
|
|
| Cash Equivalents |
5
|
9
|
1
|
0
|
8
|
16
|
12
|
30
|
38
|
57
|
0
|
11
|
169
|
155
|
27
|
31
|
43
|
62
|
8
|
100
|
48
|
221
|
145
|
286
|
|
| Short-Term Investments |
0
|
0
|
16
|
9
|
4
|
15
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
9
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
5
|
13
|
17
|
23
|
46
|
60
|
65
|
73
|
96
|
132
|
169
|
162
|
222
|
281
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
5
|
13
|
17
|
22
|
46
|
59
|
65
|
72
|
96
|
129
|
165
|
162
|
222
|
281
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
4
|
4
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
8
|
13
|
26
|
38
|
41
|
48
|
61
|
82
|
105
|
111
|
137
|
143
|
|
| Other Current Assets |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
1
|
0
|
1
|
1
|
2
|
4
|
3
|
5
|
4
|
6
|
8
|
21
|
25
|
19
|
34
|
|
| Total Current Assets |
6
|
9
|
18
|
9
|
22
|
31
|
16
|
31
|
41
|
58
|
9
|
28
|
195
|
193
|
103
|
132
|
153
|
188
|
170
|
322
|
344
|
520
|
528
|
753
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
5
|
5
|
5
|
7
|
11
|
20
|
38
|
41
|
41
|
53
|
43
|
45
|
57
|
62
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
5
|
5
|
5
|
7
|
11
|
20
|
38
|
41
|
41
|
53
|
43
|
45
|
57
|
62
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
5
|
5
|
7
|
8
|
13
|
18
|
23
|
33
|
33
|
45
|
53
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
42
|
66
|
176
|
230
|
202
|
180
|
189
|
294
|
252
|
209
|
542
|
480
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
4
|
4
|
4
|
28
|
28
|
28
|
60
|
62
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
15
|
17
|
31
|
29
|
35
|
45
|
58
|
75
|
93
|
103
|
97
|
83
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
4
|
4
|
4
|
28
|
28
|
28
|
60
|
62
|
|
| Total Assets |
6
N/A
|
10
+63%
|
18
+85%
|
10
-46%
|
22
+133%
|
31
+39%
|
18
-43%
|
36
+106%
|
45
+23%
|
62
+39%
|
14
-78%
|
45
+225%
|
260
+483%
|
285
+10%
|
323
+13%
|
412
+28%
|
431
+4%
|
457
+6%
|
461
+1%
|
772
+67%
|
760
-1%
|
904
+19%
|
1 284
+42%
|
1 440
+12%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
1
|
1
|
3
|
2
|
5
|
3
|
2
|
1
|
3
|
2
|
3
|
4
|
9
|
15
|
11
|
23
|
29
|
37
|
46
|
63
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
4
|
1
|
1
|
5
|
7
|
20
|
24
|
23
|
20
|
23
|
28
|
36
|
58
|
93
|
146
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
116
|
10
|
13
|
1
|
1
|
1
|
9
|
17
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
6
|
3
|
8
|
8
|
18
|
17
|
31
|
36
|
33
|
50
|
47
|
52
|
|
| Total Current Liabilities |
1
|
1
|
2
|
3
|
4
|
2
|
4
|
4
|
8
|
7
|
8
|
4
|
13
|
12
|
32
|
39
|
166
|
62
|
79
|
88
|
99
|
145
|
194
|
278
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
17
|
17
|
49
|
0
|
107
|
113
|
121
|
198
|
67
|
176
|
172
|
287
|
286
|
285
|
615
|
600
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
7
|
15
|
39
|
36
|
17
|
47
|
22
|
|
| Total Liabilities |
1
N/A
|
1
-31%
|
2
+111%
|
3
+47%
|
4
+54%
|
2
-65%
|
4
+160%
|
21
+428%
|
26
+24%
|
25
-4%
|
57
+130%
|
4
-94%
|
120
+3 323%
|
125
+5%
|
153
+22%
|
237
+55%
|
233
-2%
|
244
+5%
|
266
+9%
|
413
+56%
|
422
+2%
|
447
+6%
|
856
+92%
|
900
+5%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
27
|
37
|
57
|
57
|
65
|
84
|
86
|
135
|
185
|
255
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
25
|
25
|
25
|
0
|
|
| Retained Earnings |
22
|
28
|
40
|
50
|
47
|
55
|
72
|
119
|
166
|
217
|
44
|
49
|
20
|
4
|
3
|
4
|
12
|
18
|
5
|
48
|
97
|
80
|
100
|
23
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
90
|
160
|
164
|
173
|
179
|
187
|
201
|
214
|
388
|
404
|
514
|
520
|
596
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
10
|
21
|
33
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
11
|
3
|
12
|
9
|
5
|
1
|
|
| Total Equity |
5
N/A
|
9
+89%
|
16
+83%
|
7
-57%
|
18
+166%
|
30
+64%
|
14
-54%
|
16
+14%
|
19
+21%
|
38
+98%
|
43
N/A
|
41
N/A
|
140
+241%
|
160
+15%
|
170
+6%
|
175
+3%
|
197
+13%
|
213
+8%
|
196
-8%
|
359
+83%
|
339
-6%
|
458
+35%
|
429
-6%
|
541
+26%
|
|
| Total Liabilities & Equity |
6
N/A
|
10
+63%
|
18
+85%
|
10
-46%
|
22
+133%
|
31
+39%
|
18
-43%
|
36
+106%
|
45
+23%
|
62
+39%
|
14
-78%
|
45
+225%
|
260
+483%
|
285
+10%
|
323
+13%
|
412
+28%
|
431
+4%
|
457
+6%
|
461
+1%
|
772
+67%
|
760
-1%
|
904
+19%
|
1 284
+42%
|
1 440
+12%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
4
|
10
|
11
|
12
|
12
|
12
|
12
|
12
|
12
|
17
|
18
|
20
|
21
|
23
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
